XNCR Return on Tangible Equity | Xencor, Inc

Xencor, Inc (XNCR) Return on Tangible Equity

2026-06-30: Return Tang Equity -32.68%.
2026-03-31: Return Tang Equity -33.68%.
2025-12-31: Return Tang Equity -14.56%.
2025-09-30: Return Tang Equity -21.07%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-32.68%
2026-03-31	-33.68%
2025-12-31	-14.56%
2025-09-30	-21.07%
2025-06-30	-27.78%
2025-03-31	-32.72%
2024-12-31	-34.72%
2024-09-30	-29.81%
2024-06-30	-34.40%
2024-03-31	-24.14%
2023-12-31	-20.38%
2023-09-30	-18.03%
2023-06-30	-19.03%
2023-03-31	-20.68%
2022-12-31	-7.68%
2022-09-30	4.18%
2022-06-30	3.06%
2022-03-31	14.38%
2021-12-31	11.38%
2021-09-30	-0.67%
2021-06-30	3.68%
2021-03-31	-11.06%
2020-12-31	-12.26%
2020-09-30	-14.69%
2020-06-30	-14.22%
2020-03-31	-10.44%
2019-12-31	4.58%
2019-09-30	5.89%
2019-06-30	8.13%
2019-03-31	6.48%
2018-12-31	-13.65%
2018-09-30	-8.52%
2018-06-30	-13.77%
2018-03-31	-9.88%
2017-12-31	-12.40%
2017-09-30	-11.73%
2017-06-30	-6.37%
2017-03-31	12.09%
2016-12-31	13.58%
2016-09-30	20.54%
2016-06-30	18.95%
2016-03-31	-11.45%
2015-12-31	-11.21%
2015-09-30	-18.01%
2015-06-30	-14.61%
2015-03-31	-11.64%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-14.56%
2024-12-31	-34.72%
2023-12-31	-20.38%
2022-12-31	-7.68%
2021-12-31	11.38%
2020-12-31	-12.26%
2019-12-31	4.58%
2018-12-31	-13.65%
2017-12-31	-12.40%
2016-12-31	13.58%
2015-12-31	-11.21%
2014-12-31	-30.28%
2013-12-31	-81.95%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01
ANI PHARMACEUTICALS INC (ANIP)	United States	$1.810B	18.77
COMPASS Pathways plc (CMPS)		$1.812B	-4.87
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Zymeworks Inc. (ZYME)	United States	$1.902B	-12.44
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82